Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).

about

Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).

Item

http://www.wikidata.org/entity/Q39268911

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Therapeutic Targeting of PDEs ...... ved Ejection Fraction (HFpEF).

@en

Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction

@nl

type

Item

label

Therapeutic Targeting of PDEs ...... ved Ejection Fraction (HFpEF).

@en

Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction

@nl

prefLabel

Therapeutic Targeting of PDEs ...... ved Ejection Fraction (HFpEF).

@en

Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction

@nl

P1476

Therapeutic Targeting of PDEs ...... rved Ejection Fraction (HFpEF)

@en

P2093

Alessandra Murabito

http://www.w3.org/2001/XMLSchema#string

Jean Piero Margaria

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases

Roflumilast: a review of its use in the treatment of COPD

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety

PI3K signalling in inflammation.

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Outcome of heart failure with preserved ejection fraction in a population-based study

Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases

Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice

P2888

s11897-017-0331-2

P304

187-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-017-0331-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28451983

http://www.w3.org/2001/XMLSchema#string